Transcatheter Interatrial Shunt Device Provides Sustained Clinical Benefit at One Year in Patients With Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

2016 | conference abstract. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Transcatheter Interatrial Shunt Device Provides Sustained Clinical Benefit at One Year in Patients With Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial​
Kaye, D.; Hasenfuß, G. ; Neuzil, P.; Post, M.; Doughty, R.; Trochu, J.-N. & Kolodziej, A. et al.​ (2016)
Circulation, 134(25) , New Orleans, LA.
Philadelphia​: Lippincott Williams & Wilkins.

Copy

Further links

Documents & Media

License

GRO License GRO License

Details

Authors
Kaye, David; Hasenfuß, Gerd ; Neuzil, Petr; Post, Marco; Doughty, Rob; Trochu, Jean-Noel; Kolodziej, Adam; Westenfeld, Ralf; Penicka, Martin; Rosenberg, Mark; Hausleiter, Joerg; Raake, Philip; Petrie, Mark C.; Bergmann, Martin; Jondeau, Guillaume; Silvestry, Frank; Hayward, Chris
Issue Date
2016
Status
published
Publisher
Lippincott Williams & Wilkins
Journal
Circulation 
Conference Place
New Orleans, LA
ISSN
1524-4539; 0009-7322
Extent
E707

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations